• Cytek Biosciences director Glenn P. Muir filed an initial Form 3 on June 12 covering holdings as of June 10.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytek Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001181190-26-000004), on June 12, 2026, and is solely responsible for the information contained therein.